BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee AJ, Wu AG, Yew KC, Shelat VG. Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis. World J Gastrointest Surg 2023; 15(2): 273-286 [PMID: 36896301 DOI: 10.4240/wjgs.v15.i2.273]
URL: https://www.wjgnet.com/1948-5182/full/v15/i2/273.htm
Number Citing Articles
1
Vishal G Shelat. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapyWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4037-4041 doi: 10.4251/wjgo.v16.i10.4037
2
Xiaodong Zhang, Luyi Zhang, Shuangying Zhao, Lingling Dai, Huayu Li, Xudong Wu, Huanjun Yan, Rongfeng Lin, Kelei Zhu. Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case reportFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1529016
3
Chunwei Kou, Ren Ji, Hongtao Zhu, Weitian Fan, Limin Fan, Chan Chi Yan Albert. Should associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) be used in giant liver cancer?Current Problems in Surgery 2025; : 101840 doi: 10.1016/j.cpsurg.2025.101840